Both proteasomes and lysosomes degrade the activated erythropoietin receptor.
暂无分享,去创建一个
Frédérique Verdier | Patrick Mayeux | C. Lacombe | F. Verdier | P. Mayeux | S. Chrétien | Catherine Lacombe | Pierre Walrafen | Zahra Kadri | Stany Chrétien | P. Walrafen | Z. Kadri
[1] V. Broudy,et al. Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs. , 2003, Blood.
[2] M. Ciesielski,et al. Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function , 2000, Oncogene.
[3] P. Mayeux,et al. The erythropoietin receptor of rat erythroid progenitor lens. Characterization and affinity cross-linkage. , 1987, The Journal of biological chemistry.
[4] Yosef Yarden,et al. Endocytosis of Receptor Tyrosine Kinases Is Driven by Monoubiquitylation, Not Polyubiquitylation* , 2003, Journal of Biological Chemistry.
[5] T. Malek,et al. The Proteasome Regulates Receptor-mediated Endocytosis of Interleukin-2* , 2001, The Journal of Biological Chemistry.
[6] Rey-Huei Chen,et al. Molecular interpretation of ERK signal duration by immediate early gene products , 2002, Nature Cell Biology.
[7] F. Verdier,et al. Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors. , 2000, The Journal of biological chemistry.
[8] D. Nimbalkar,et al. Erythropoietin Receptors Associate with a Ubiquitin Ligase, p33RUL, and Require Its Activity for Erythropoietin-induced Proliferation* , 2003, Journal of Biological Chemistry.
[9] A. Levitzki,et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor , 1996, Nature.
[10] S. Fuchs,et al. SCFHOS ubiquitin ligase mediates the ligand‐induced down‐regulation of the interferon‐α receptor , 2003 .
[11] A. Dautry‐Varsat,et al. Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments. , 2001, Molecular biology of the cell.
[12] P. van Kerkhof,et al. The ubiquitin-proteasome pathway regulates lysosomal degradation of the growth hormone receptor and its ligand. , 2001, Biochemical Society transactions.
[13] N. Copeland,et al. A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors. , 1995, The EMBO journal.
[14] H. Beug,et al. FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1 , 2004, The Journal of cell biology.
[15] L. Platanias,et al. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1 , 1996, Molecular and cellular biology.
[16] Stefan N. Constantinescu,et al. The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction , 1999, Trends in Endocrinology & Metabolism.
[17] A. Dautry‐Varsat,et al. Down-regulation of high affinity interleukin 2 receptors in a human tumor T cell line. Interleukin 2 increases the rate of surface receptor decay. , 1988, The Journal of biological chemistry.
[18] H. Nakauchi,et al. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. , 1991, Cancer research.
[19] C. Marshall,et al. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.
[20] M. Martinez-Moczygemba,et al. Proteasomal regulation of betac signaling reveals a novel mechanism for cytokine receptor heterotypic desensitization. , 2001, The Journal of clinical investigation.
[21] B. Deurs,et al. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. , 1999, Molecular biology of the cell.
[22] N. Casadevall,et al. Solubilization and hydrodynamic characteristics of the erythropoietin receptor. Evidence for a multimeric complex. , 1990, European journal of biochemistry.
[23] G. Strous,et al. Dimerization, ubiquitylation and endocytosis go together in growth hormone receptor function , 2002, FEBS letters.
[24] S. Ruscetti,et al. Involvement of the Ubiquitin-Proteasome Pathway in the Degradation of Nontyrosine Kinase-Type Cytokine Receptors of IL-9, IL-2, and Erythropoietin1 , 2000, The Journal of Immunology.
[25] H. Lodish,et al. The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. , 2001, Molecular cell.
[26] A. Barrett,et al. CA074 methyl ester: a proinhibitor for intracellular cathepsin B. , 1992, Archives of biochemistry and biophysics.
[27] Y. Yarden,et al. The role of ubiquitylation in signaling by growth factors: implications to cancer. , 2003, Seminars in cancer biology.
[28] K Kobylarz,et al. Acute cholesterol depletion inhibits clathrin-coated pit budding. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] P. van Kerkhof,et al. Endocytosis and Degradation of the Growth Hormone Receptor Are Proteasome-dependent* , 2000, The Journal of Biological Chemistry.
[30] N. Casadevall,et al. Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. , 1992, The Journal of biological chemistry.
[31] I. Dusanter-Fourt,et al. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway , 1997, Molecular and cellular biology.
[32] A. Yoshimura,et al. CIS3/SOCS-3 Suppresses Erythropoietin (EPO) Signaling by Binding the EPO Receptor and JAK2* , 2000, The Journal of Biological Chemistry.
[33] V. Broudy,et al. Erythropoietin receptor characteristics on primary human erythroid cells. , 1991, Blood.
[34] T. ten Broeke,et al. Growth Hormone Receptor Ubiquitination, Endocytosis, and Degradation Are Independent of Signal Transduction via Janus Kinase 2* , 2001, The Journal of Biological Chemistry.
[35] G. Strous,et al. The ubiquitin–proteasome pathway and the regulation of growth hormone receptor availability , 2002, Molecular and Cellular Endocrinology.
[36] W. Cavenee,et al. Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] Patrick Mayeux,et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. , 2002, The New England journal of medicine.
[38] P. Mayeux,et al. Erythropoietin (Epo) receptor and Epo mimetics. , 1999, Advances in nephrology from the Necker Hospital.
[39] D. Reijngoud,et al. Relationship between medium pH and that of the lysosomal matrix as studied by two independent methods. , 1976, Biochimica et biophysica acta.
[40] Olivier Hermine,et al. Caspase Activation Is Required for Terminal Erythroid Differentiation , 2001, The Journal of experimental medicine.
[41] D. Neumann,et al. Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes. , 1993, The Journal of biological chemistry.
[42] G. Longmore,et al. Activation of the erythropoietin receptor is not required for internalization of bound erythropoietin. , 1999, Blood.
[43] A. Dautry‐Varsat,et al. Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. , 2001, Molecular cell.
[44] B. Avalos,et al. Deletion of a critical internalization domain in the G-CSFR in acute myelogenous leukemia preceded by severe congenital neutropenia. , 1999, Blood.
[45] I. Touw,et al. Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia. , 1999, Blood.
[46] Ursula Klingmüller,et al. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.
[47] Zhixiang Wang,et al. Internalization of Inactive EGF Receptor into Endosomes and the Subsequent Activation of Endosome-Associated EGF Receptors , 2002, Science's STKE.
[48] C. Lacombe,et al. Erythropoietin Induces the Tyrosine Phosphorylation of Insulin Receptor Substrate-2 , 1997, The Journal of Biological Chemistry.
[49] S. Fuchs,et al. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. , 2003, The EMBO journal.
[50] H. Lodish,et al. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[51] C. Lacombe,et al. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. , 2003, Blood.
[52] A. Yoshimura,et al. Proteasomes Regulate Erythropoietin Receptor and Signal Transducer and Activator of Transcription 5 (STAT5) Activation , 1998, The Journal of Biological Chemistry.
[53] Z. Kam,et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. , 1998, Genes & development.
[54] E Morelon,et al. Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains , 1995, The Journal of cell biology.